Nifedipine ER 30 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nifedipine ER 30 mg, covering 2026-03-04 to 2026-03-04. Get the full timeline:
Most recent: Clinical Trial Update: PHASE III, RANDOMIZED, ACTIVE-COMPARATOR CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF NIFEDIPINE 30MG EXTENDED-RELEASE IN ADULT PATIENTS DIAGNOSED WITH MILD OR MODERATE HYPERTENSION IN COLOMBIA. [Phase 3]